McKesson Announces Planned CFO Transition, Appoints Experienced Finance Leader
MCK sits 55% above its 52-week low of $621.88.
Summary
McKesson announced the planned retirement of its long-time CFO, Britt Vitalone, and the appointment of Kenny Cheung, an experienced finance leader with a background in large corporations and restructuring, as his successor.
Key Events · Executive and Board Changes · MCK
-
CFO Retirement Announced
Britt J. Vitalone, Executive Vice President and Chief Financial Officer for over eight years, gave notice of his intention to retire, effective May 28, 2026.
-
New CFO Appointed
Kenny K. Cheung was appointed as the new Executive Vice President and Chief Financial Officer, effective May 29, 2026. Mr. Cheung previously served as CFO at Sysco Corporation and notably guided The Hertz Corporation through its Chapter 11 restructuring.
-
Outgoing CFO to Serve as Advisor
Mr. Vitalone will transition to a non-employee advisory role from July 2, 2026, providing strategic guidance, particularly for the planned separation of McKesson Medical Surgical Solutions, for a monthly fee of $50,000.
-
New CFO Compensation Package
Mr. Cheung's compensation includes a $3.5 million sign-on bonus, $6 million in sign-on restricted stock units, an annual base salary of $1.05 million, and eligibility for an annual bonus and additional equity awards.
Analysis · MCK · Trade & Services
The planned retirement of a long-serving CFO is a significant event for a company of McKesson's scale. However, the orderly transition, including the outgoing CFO's advisory role for the strategic Medical Surgical Solutions separation, mitigates potential disruption. The appointment of Kenny Cheung, with his extensive experience including guiding Hertz through Chapter 11 restructuring and his recent role at Sysco, signals a strong and capable successor. This change is well-managed and brings in a highly qualified executive.
At the time of this filing, MCK was trading at $965.00 on NYSE in the Trade & Services sector, with a market capitalization of approximately $119.9B. The 52-week trading range was $621.88 to $999.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.